IL10 and infectious disease: Studies show that, for some infectious diseases, an increase in IL-10 potentially acts to decrease the deleterious effects of inflammation derived from Th1 cytokines without affecting the clearance of infectious agents [121–124], such as Listeria monocytogenes, Trypanosoma cruzi, and influenza virus [125–127].